Description |
Stigmasterol is a plant sterol which has been focused on the cholesterol-lowering activity and is valued as an anti-stiffness factor in the therapy of rheumatic diseases.
|
Target |
MMP[1]
|
In Vitro |
Preincubation of Stigmasterol to IL-1beta-treated cells shows significant reduction of MMP-3 mRNA in human and mouse, MMP-3 protein in mouse, MMP-13 mRNA in mouse and human, ADAMTS-4 mRNA in human, PGE2 protein in human and mouse. Stigmasterol is also capable of counteracting the IL-1beta-induced NF-κB pathway[1].
|
Cell Assay |
A model of newborn mouse chondrocytes and human osteoarthritis (OA) chondrocytes are used in primary culture stimulated with or without IL-1β (10 ng/mL), for 18 h. Cells are pre-incubated with Stigmasterol (20 mg/mL) for 48 h[1].
|
Density | 1.0±0.1 g/cm3 |
Boiling Point | 501.1±19.0 °C at 760 mmHg |
Flash Point | 219.4±13.7 °C |
Exact Mass | 412.370514 |
PSA | 20.23000 |
LogP | 10.21 |
Vapour Pressure | 0.0±2.9 mmHg at 25°C |
Storage condition | 2~8°C |